Initial data from the phase 3 KEYNOTE-811 study of trastuzumab and chemotherapy with or without pembrolizumab for HER2-positive metastatic gastric or gastroesophageal junction (G/GEJ) cancer Meeting Abstract
| Authors: | Janjigian, Y.; Kawazoe, A.; Weber, P.; Luo, S.; Lonardi, S.; Kolesnik, O.; Barajas, O.; Bai, Y.; Shen, L.; Tang, Y.; Wyrwicz, L.; Shitara, K.; Qin, S.; Van Cutsem, E.; Tabernero, J.; Li, L.; Shih, C.; Bhagia, P.; Chung, H. |
| Abstract Title: | Initial data from the phase 3 KEYNOTE-811 study of trastuzumab and chemotherapy with or without pembrolizumab for HER2-positive metastatic gastric or gastroesophageal junction (G/GEJ) cancer |
| Meeting Title: | ESMO 23rd World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2021 Jun 30-Jul 3 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-07-01 |
| Start Page: | S227 |
| Language: | English |
| ACCESSION: | WOS:000670004200349 |
| DOI: | 10.1016/j.annonc.2021.06.011 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA-4 -- Source: Wos |
